791814-38-5

Basic information

• Product Name: 2-[2-(tetrahydropyran-2-yloxy)ethoxy]phenylboronic acid
• Synonyms: 2-[2-(tetrahydropyran-2-yloxy)ethoxy]phenylboronic acid
• CAS NO: 791814-38-5
• Molecular Weight: 250.102
• Mol File: 791814-38-5.mol

Chemical Properties

• CAS DataBase Reference: 2-[2-(tetrahydropyran-2-yloxy)ethoxy]phenylboronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[2-(tetrahydropyran-2-yloxy)ethoxy]phenylboronic acid(791814-38-5)
• EPA Substance Registry System: 2-[2-(tetrahydropyran-2-yloxy)ethoxy]phenylboronic acid(791814-38-5)

Safety Data

• Hazardous Substances Data: 791814-38-5(Hazardous Substances Data)

Upstream product

• 110-87-2 3,4-dihydro-2H-pyran 
• 1074-16-4 2-bromophenylethyl alcohol 
• 143888-88-4 2-(2-bromophenyl)ethyl tetrahydro-2H-pyran-2-yl ether 

Downstream Products

• 791814-40-9 6-{2-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-phenyl}-benzo[1,3]dioxole-5-carbaldehyde 
• 791814-79-4 methanesulfonic acid 2-[2-(6-{3-[tert-butoxycarbonyl-(1-phenyl-ethyl)-amino]-propyl}-benzo[1,3]dioxol-5-yl)-phenyl]-ethyl ester 
• 791814-62-5 [3-(4-methoxy-6-{2-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-phenyl}-benzo[1,3]dioxol-5-yl)-propyl]-methyl-carbamic acid tert-butyl ester 
• 791814-42-1 5-[(E)-Cyclohexyliminomethyl]-6-{2-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-phenyl}-benzo[1,3]dioxol-4-ol 
• 791814-60-3 methyl-[3-(6-{2-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-phenyl}-benzo[1,3]dioxol-5-yl)-propyl]-carbamic acid tert-butyl ester 
• 791814-78-3 (3-{6-[2-(2-hydroxy-ethyl)-phenyl]-benzo[1,3]dioxol-5-yl}-propyl)-(1-phenyl-ethyl)-carbamic acid tert-butyl ester 
• 791814-66-9 methanesulfonic acid 2-(2-{6-[3-(tert-butoxycarbonyl-methyl-amino)-propyl]-7-methoxy-benzo[1,3]dioxol-5-yl}-phenyl)-ethyl ester 
• 791814-58-9 3-(4-methoxy-6-{2-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-phenyl}-benzo[1,3]dioxol-5-yl)-N-methyl-propionamide 
• 791814-64-7 methanesulfonic acid 2-(2-{6-[3-(tert-butoxycarbonyl-methyl-amino)-propyl]-benzo[1,3]dioxol-5-yl}-phenyl)-ethyl ester 
• 1027510-17-3 [3-(4-methoxy-6-{2-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-phenyl}-benzo[1,3]dioxol-5-yl)-propyl]-methyl-amine 
• 1027047-91-1 Methanesulfonic acid 2-(2-{6-[3-((S)-1-phenyl-ethylamino)-propyl]-benzo[1,3]dioxol-5-yl}-phenyl)-ethyl ester 
• 791814-56-7 N-methyl-3-(6-{2-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-phenyl}-benzo[1,3]dioxol-5-yl)-propionamide 
• 1026682-09-6 (3-{6-[2-(2-hydroxy-ethyl)-phenyl]-4-methoxy-benzo[1,3]dioxol-5-yl}-propyl)-methyl-carbamic acid tert-butyl ester 
• 791814-54-5 3-(4-methoxy-6-{2-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-phenyl}-benzo[1,3]dioxol-5-yl)-N-methyl-acrylamide 

Relevant articles and documents

Synthesis of the enantiomers of hexahydrodibenz[d,f]azecines

Suzuki coupling procedures were used to make appropriate 2-(3-aminopropyl)-2′-(2-mesyloxy)-ethyl disubstituted biphenyl derivatives 19 and 20 from which the racemic hexahydrodibenz[d,f]-azecines 3 and 4 were produced following intramolecular mesyloxy disp

Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors

We report a new series of hepatitis C virus NS5B RNA polymerase inhibitors containing a conformationally constrained tetracyclic scaffold. SAR studies led to the identification of 6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indoles (19 and 20) bearing a basic pendent group with high biochemical and cellular potencies. These compounds displayed a very small shift in cellular potency when the replicon assay was performed in the presence of human serum albumin.